#124794

Biostar is committed to the R&D of microbial metabolites innovative drugs, and has established advanced, unique and sustainable core technology platforms, including combinatorial biosynthesis, microbial fermentation production, microbial drugs formulation development platforms.

Through combinatorial biosynthesis technology platform, we can conduct mechanism research of compound biosynthesis and drug molecular design, to identify the candidates with high druggablity. Then biosynthetic genes are modified by genetic engineering techniques, and homologous or heterologous host expression systems are constructed, to obtain modified strains with industrialization potential. Through microbial fermentation production technology platform, we can design the fermentation process, including the settings of culture medium and the study of CQAs. Through microbial drugs formulation development technology platform, we can solve the bottleneck of formulation for such molecules to improve the druggability and the compliance for clinical use.

#124794

#124794

#124794

#124794

#124794